Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Husain

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Focus (American Psychiatric Publishing)|May 2, 2024
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar DepressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Eclinicalmedicine|May 30, 2024
Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trialJeffrey H Meyer, ZhaoHui Wang, Apitharani Santhirakumar, et al.
Translational Psychiatry|September 2, 2021
Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosisI B Chaudhry, M O Husain, A B Khoso, et al.
Trials|July 3, 2024
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionJoshua M Poulin, Gregory E Bigford, Krista L Lanctôt, et al.
Translational Psychiatry|December 1, 2020
A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosisI B Chaudhry, M O Husain, A B Khoso, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
Journal of Affective Disorders|February 29, 2024
The role of interpersonal stressors and connectedness in acute suicide risk and the suicide crisis syndrome during the COVID-19 pandemicYarden Blum, Shannel Akhavan, Megan L Rogers, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 3, 2022
A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorderLicia P Luna, Joaquim Radua, Lydia Fortea, et al.
Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
BMC Psychiatry|June 16, 2023
Culturally adapted psychosocial interventions (CaPSI) for early psychosis in a low-resource setting: study protocol for a large multi-center RCTM O Husain, A B Khoso, T Kiran, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Focus (American Psychiatric Publishing)|May 2, 2024
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar DepressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Eclinicalmedicine|May 30, 2024
Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trialJeffrey H Meyer, ZhaoHui Wang, Apitharani Santhirakumar, et al.
Translational Psychiatry|September 2, 2021
Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosisI B Chaudhry, M O Husain, A B Khoso, et al.
Trials|July 3, 2024
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionJoshua M Poulin, Gregory E Bigford, Krista L Lanctôt, et al.
Translational Psychiatry|December 1, 2020
A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosisI B Chaudhry, M O Husain, A B Khoso, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
Journal of Affective Disorders|February 29, 2024
The role of interpersonal stressors and connectedness in acute suicide risk and the suicide crisis syndrome during the COVID-19 pandemicYarden Blum, Shannel Akhavan, Megan L Rogers, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 3, 2022
A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorderLicia P Luna, Joaquim Radua, Lydia Fortea, et al.
Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
BMC Psychiatry|June 16, 2023
Culturally adapted psychosocial interventions (CaPSI) for early psychosis in a low-resource setting: study protocol for a large multi-center RCTM O Husain, A B Khoso, T Kiran, et al.
Pageof 14